Skip to main content
. 2019 Sep 19;10:642. doi: 10.3389/fendo.2019.00642

Table 3.

Logistic regression based on the occurrence of live birth in the first stimulation cycle.

Variable Non-live birth (n = 11,293) Live birth (n = 8,488) Univariable logistic regression Multivariable logistic regression
OR (95% CI) P OR (95% CI) P
Grouping, n (%)
   POSEIDON group 1 5,293 (43.96) 6,747 (56.04) Reference Reference
   POSEIDON group 2 3,353 (69.15) 1,496 (30.85) 2.857 (2.662, 3.067) <0.001 2.319 (2.131, 2.525) <0.001
   POSEIDON group 3 573 (85.27) 99 (14.73) 7.378 (5.943, 9.16) <0.001 1.356 (1.005, 1.828) 0.046
   POSEIDON group 4 2,074 (93.42) 146 (6.58) 18.104 (15.249, 21.493) <0.001 3.525 (2.774, 4.479) <0.001
Baseline FSH, mean ± SD 7.37 ± 3.89 6.3 ± 2.36 1.150 (1.136, 1.165) <0.001 1.017 (1.0, 1.034) 0.053
Baseline LH, mean ± SD 4.01 ± 2.56 4.28 ± 2.79 0.962 (0.952, 0.973) <0.001 0.979 (0.965, 0.993) 0.003
Baseline E2, mean ± SD 42.8 ± 45.87 37.83 ± 25.61 1.006 (1.005, 1.007) <0.001 1.002 (1.001, 1.004) 0.001
BMI, n (%)
    <18.5 757 (6.70) 719 (8.47) 0.786 (0.706, 0.875) <0.001 1.014 (0.891, 1.154) 0.831
   18.5–25 8,759 (77.56) 6,540 (77.05) Reference Reference
   >25 1,777 (15.74) 1,229 (14.48) 1.080 (0.997, 1.169) 0.059 1.033 (0.938, 1.138) 0.505
Duration of infertility, mean ± SD 5.57 ± 4.47 4.42 ± 3.25 1.079 (1.071, 1.088) <0.001 1.023 (1.013, 1.033) <0.001
Cause of infertility, n (%)
   Tubal cause 10,309 (91.29) 7,762 (91.45) 0.98 (0.886, 1.083) 0.692
   Ovulation disorder 58 (0.51) 83 (0.98) 0.523 (0.373, 0.732) <0.001 1.049 (0.722, 1.524) 0.803
   Endometriosis 1,078 (9.55) 777 (9.15) 1.047 (0.95, 1.154) 0.351
   Male cause 3,368 (29.82) 2,816 (33.18) 0.856 (0.806, 0.909) <0.001 0.991 (0.920, 1.068) 0.817
   Others 193 (1.71) 133 (1.57) 1.092 (0.874, 1.364) 0.44
   Multiple causes 10,911 (96.62) 8,279 (97.54) 0.721 (0.608, 0.856) <0.001 0.932 (0.758, 1.146) 0.502
Method of fertilization, n (%)
   IVF 8,853 (78.39) 6,712 (79.08) Reference
   ICSI 2,440 (21.61) 1,776 (20.92) 1.042 (0.972, 1.116) 0.247
Ovarian stimulation protocol, n (%)
   Long GnRH agonist protocol 7,192 (63.69) 7,773 (91.58) Reference Reference
   GnRH antagonist protocol 2,630 (23.29) 653 (7.69) 4.353 (3.972, 4.77) <0.001 1.856 (1.640, 2.100) <0.001
Others 1,471 (13.03) 62 (0.73) 25.642 (19.848, 33.128) <0.001 1.651 (1.155, 2.361) 0.006
Fresh embryo/frozen embryo, n (%)
   Fresh embryo transfer 7,510 (66.50) 6,927 (81.61) Reference Reference
   Fresh and frozen embryo transfer 3,783 (33.50) 1,561 (18.39) 2.235 (2.089, 2.39) <0.001 2.772 (2.567, 2.993) <0.001
Number of embryos transferred, n (%)
   0 3,998 (35.4) 0 (0) >999.999 (0, >999.999) 0.903 >999.999 (0, >999.999) 0.973
   1 1,938 (17.16) 945 (11.13) Reference Reference
   2 5,296 (46.9) 7,503 (88.4) 0.344 (0.316, 0.375) <0.001 0.514 (0.468, 0.565) <0.001
   3 61 (0.54) 40 (0.47) 0.744 (0.495, 1.116) 0.153 0.747 (0.483, 1.155) 0.190

Data are shown as number of patients (percentage) or mean ± SD. OR, odd ratio; CI, confidence interval; BMI, body mass index; FSH, follicular-stimulating hormone; SD, standard deviation; LH, luteinizing hormone; E2, estradiol; P: progesterone; PRL, prolactin; AMH, anti-Müllerian hormone; AFC, antral follicular count; OHSS, ovarian hyperstimulation syndrome; GnRH, gonadotropin-releasing hormone; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection.